Literature DB >> 10374931

Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.

Y Nozawa1, N Matsuura, H Miyake, S Yamada, R Kimura.   

Abstract

We investigated the effects of TH-142177 (N-n-butyl-N-[2'-(1-H-tetrazole-5-yl) biphenyl-4-yl]-methyl-(N-carboxy methyl-benzylamino)-acetamide), a novel selective antagonist of angiotensin II type 1-receptor (AT1-R) on angiotensin II (AII)-induced proliferation and migration of vascular smooth muscle cells (VSMC), and on neointimal formation in the rat carotid artery after balloon injury, and on the intracellular signaling by the stimulation of AT1-R. High affinity AII receptor sites were detected in rat VSMC by the use of [125I]Sar1,Ile8-AII. TH-142177 and losartan competed with [125I]Sar1,Ile8-AII for the binding sites in VSMC in a monophasic manner, although PD123177, a selective antagonist of angiotensin II type 2-receptor (AT2-R), had little inhibitory effect, demonstrating the predominant existence of AT1-R in rat VSMC. TH-142177 prevented AII-induced DNA synthesis and migration, with a significant inhibition of 74 and 55%, respectively, at the concentration of 100 nM. AII-induced activation of p21ras, mitogen-activated protein kinase (p42MAPK and p44MAPK), and protein kinase C was significantly (50-78%) inhibited by TH-142177 (100 nM), suggesting that the activation of these enzymes is mediated through the stimulation of AT1-R. Balloon-injured left carotid arteries in rats showed extensive neointimal thickening, and TH-142177 (3 mg/kg) brought out a marked decrease in the neointimal thickening after balloon injury. In conclusion, TH-142177 inhibited AII-induced proliferation and migration of rat VSMC and neointimal formation in the carotid artery after balloon injury, and these effects may be related, in part, to the suppression of ras, p42MAPK and p44MAPK, and protein kinase C activities through the blockade of AT1-R. Thus, TH-142177 may have therapeutic potential for the treatment of vascular diseases such as atherosclerosis and restenosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10374931     DOI: 10.1016/s0024-3205(99)00153-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Angiotensin II stimulates melanogenesis via the protein kinase C pathway.

Authors:  Li-Hong Liu; Xin Fan; Zhi-Kuan Xia; Xu-Xi An; Rong-Ya Yang
Journal:  Exp Ther Med       Date:  2015-08-14       Impact factor: 2.447

2.  Losartan Inhibits Vascular Smooth Muscle Cell Proliferation through Activation of AMP-Activated Protein Kinase.

Authors:  Jung Eun Kim; Hyoung Chul Choi
Journal:  Korean J Physiol Pharmacol       Date:  2010-10-31       Impact factor: 2.016

3.  High glucose blocks the effects of estradiol on human vascular cell growth: differential interaction with estradiol and raloxifene.

Authors:  Dalia Somjen; Channing J Paller; Batya Gayer; Fortune Kohen; Esther Knoll; Naftali Stern
Journal:  J Steroid Biochem Mol Biol       Date:  2004-01       Impact factor: 4.292

4.  Candesartan treatment for peripheral occlusive arterial disease after stent angioplasty : a randomised, placebo-controlled trial.

Authors:  C Schindler; J Schweizer; A Müller; R Koch; G Hellner; W Fuchs; W Kirch
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

5.  Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.

Authors:  Jihee Kim; Seungkirl Ahn; Keshava Rajagopal; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2009-03-02       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.